Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Zambrano Chacon (Madrid, Spain), L. Núñez García (Madrid, Spain), C. Gotera Rivera (Madrid, Spain), M. Pérez Warnisher (Madrid, Spain), R. Melchor Iñiguez (Madrid, Spain), E. Pinillos Robles (Madrid, Spain), E. Cabezas Pastor (Madrid, Spain), A. El Hachem Debek (Madrid, Spain), M. Rodríguez Guzmán (Madrid, Spain), P. Lazo Meneses (Madrid, Spain), J. Alfayate Sanchez (Madrid, Spain), N. Mangado (Madrid, Spain), G. Peces-Barba Romero (Madrid, Spain), L. Seijo Maceiras (Madrid, Spain). Lung Cancer Prevalence after 4 years of screening in a COPD/Emphysema centered screening program. 3024

Member's Comments

No comment yet.

Related content which might interest you: Contamination during 4-5 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST) Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Lung Cancer screening: is there any role for molecular testing Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 The results of the prevalence screen in Lung SEARCH: A UK based screening trial for lung cancer based on sputum cytology and cytometry, by the Lung SEARCH screening group Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Computed tomographic screening for lung cancer: individualising the benefit of the screening Source: Eur Respir J 2007; 30: 843-847 Year: 2007 Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Lung cancer screening - where we are and how to implement it Source: International Congress 2018 – ME5 Lung cancer screening Year: 2018 Active TB in cancer patients: A missed screening opportunity? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Population’s understanding and degree of participation of a screening lung cancer programme Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Newborn Screening for Cystic Fibrosis in Wales over 20 years. Changes in incidence dependent on screening protocol Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Latent tuberculosis infection and the risk of cancer: A nationwide population-based study Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Evaluating 17 years of LTBI screening in NW England Source: International Congress 2016 – Latent tuberculosis infection Year: 2016 Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Performance of segmentation software on large longitudinal database of pulmonary nodules in the Danish Lung Cancer Screening Trial (DLCST) Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 EGFR-mutated lunge cancer in a general Norwegian population Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Lung cancer in women: A seven years study in Eastern Algeria Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Electronic nose as a screening tool for early stage lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014